NOGGO

ENGOT-OV62/ NOGGO OV 53/ N-Plus

A Phase III randomized, open label study of NiraParib maintenance after Carboplatin and Paclitaxel in optimaLly debUlked advanced HRDpositive high grade ovarian cancer patientS in first line therapy

Trial Number
NCT05460000 (ClinicalTrials.gov Identifier)
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number

ENGOT-OV47/ NOGGO TR2/ HELP-ER

Prospective Study of HE4 serum Level in Patients with First Platinum Sensitive Ovarian Cancer Relapse

Trial Number
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number

ENGOT-EN16/ NOGGO S22/ Expression XI

IMPROVE - International Survey for Endometrial Cancer patients: perspective and expectation on therapy and quality of life

Trial Number
DRKS00025954
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number

ENGOT-OV22/ NOGGO S8 / Expression IV

Ovarian cancer patients’ expectations in respect of maintenance therapy 

Trial Number
Contact Person
Status
Disease Site
Lead Cooperative Group
Participating Groups
GCIG Number
Subscribe to NOGGO